Author:
Antúnez Gabriela,Merino Tomás
Abstract
INTRODUCTION Brain metastases are a common problem in oncology patients, especially in lung cancer. The usual treatment for cerebral oligometastases is whole brain radiation therapy. Given the persistent poor prognosis of this disease, other therapeutic alternatives such as stereotactic radiosurgery have been considered. However, there is no clarity regarding the effectiveness of its addition. METHODS We searched in Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies, conducted a meta-analysis and generated a summary of findings table using the GRADE approach. RESULTS AND CONCLUSIONS We identified 17 systematic reviews including seven studies overall, of which four were randomized trials. All trials assessed patients with brain oligometastases, but none of them included exclusively lung cancer population. We concluded that it is not possible to clearly establish whether radiosurgery decreases neurological functionality, cognitive impairment, mortality or serious adverse effects, as the certainty of the existing evidence has been assessed as very low.
Publisher
Medwave Estudios Limitada
Reference28 articles.
1. Villaruz LC, Kubicek GJ, Socinski MA. Management of non-small cell lung cancer with oligometastases. Curr Oncol Rep. 2012 Aug;14(4):333-41. | CrossRef | PubMed | PMC |
2. Khan M, Lin J, Liao G, Tian Y, Liang Y, Li R, Liu M, Yuan Y. Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of BrainMetastases Leading to Improved Survival in Patients With Favorable Prognostic Factors. Front Oncol. 2019 Mar 29;9:205. | CrossRef | PubMed | PMC |
3. Cohen-Inbar O, Sheehan JP. The role of stereotactic radiosurgery and whole brain radiation therapy as primary treatment in the treatment of patients with brain oligometastases - A systematic review. J Radiosurg SBRT. 2016;4(2):79-88. | PubMed | PMC |
4. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46. | PubMed |
5. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, Ammirati M, Cobbs CS, Gaspar LE, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Kalkanis SN. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010 Jan;96(1):45-68. | CrossRef | PubMed | PMC |